(Q44850012)

6 December 2017

title

Portal and peripheral cortisol levels in obese humans (English)

1 reference

6 December 2017

0 references

W Aldhahi

1

1 reference

6 December 2017

E Mun

series ordinal

2

1 reference

6 December 2017

A B Goldfine

series ordinal

3

1 reference

6 December 2017

publication date

17 April 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

47

1 reference

6 December 2017

issue

5

1 reference

6 December 2017

page(s)

833-836

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-004-1389-4

6 December 2017

exact match

0 references

cites work

Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome

1 reference

12 December 2020

Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.

1 reference

12 December 2020

Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians

1 reference

12 December 2020

Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure

1 reference

12 December 2020

Cortisol secretion in relation to body fat distribution in obese premenopausal women

1 reference

12 December 2020

Does central obesity reflect "Cushing's disease of the omentum"?

1 reference

12 December 2020

Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation

1 reference

12 December 2020

Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice

1 reference

12 December 2020

Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium

1 reference

12 December 2020

Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome

1 reference

12 December 2020

Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats

1 reference

12 December 2020

11beta-hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative disease

1 reference

12 December 2020

Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action

1 reference

12 December 2020

Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity

1 reference

12 December 2020

A transgenic model of visceral obesity and the metabolic syndrome

1 reference

12 December 2020

Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action

1 reference

12 December 2020

Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study

1 reference

12 December 2020

Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.

1 reference

12 December 2020

10.1007/S00125-004-1389-4

Identifiers

DOI

1 reference

6 December 2017

1 reference